Legend Biotech (LEGN) Non-Current Deffered Revenue (2020 - 2025)
Legend Biotech's Non-Current Deffered Revenue was $651,000 in Q2 2025, up 19.4% from $545,000 a year earlier and up 21.7% from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) Non-Current Deffered Revenue (2020 - 2025) Analysis & Trends
At the end of FY2024, Non-Current Deffered Revenue at Legend Biotech came in at $532,000, up 682.4% from FY2023.
- Non-Current Deffered Revenue shows a four-year compound annual growth rate of 17.1% (FY2020 to FY2024).
- In earlier years, Non-Current Deffered Revenue was $68,000 in FY2023 (-84.9%), $451,000 in FY2022 (+48.4%), $304,000 in FY2021 (+7.4%) and $283,000 in FY2020.
- The Q2 2025 figure marks the highest quarterly Non-Current Deffered Revenue since Q3 2020.
- Compared with a year earlier, Non-Current Deffered Revenue was higher in four of the last seven quarters, with growth averaging 92.5%.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2024 (growth of 682.4%); the worst was Q3 2021 (a decline of 85.3%).
- Per Business Quant data, LEGN's Non-Current Deffered Revenue in the three quarters before Q2 2025 was $535,000 (Q1 2025), $532,000 (Q4 2024) and $554,000 (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Legend Biotech | 3.56 Bn | -179.32 Mn | 251.50 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 651,000.00 |
| Mar 31, 2025 | 535,000.00 |
| Dec 31, 2024 | 532,000.00 |
| Sep 30, 2024 | 554,000.00 |
| Jun 30, 2024 | 545,000.00 |
| Mar 31, 2024 | 538,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Sep 30, 2023 | 630,000.00 |
| Jun 30, 2023 | 435,000.00 |
| Mar 31, 2023 | 457,000.00 |
| Dec 31, 2022 | 451,000.00 |
| Mar 31, 2022 | 320,000.00 |
| Dec 31, 2021 | 304,000.00 |
| Sep 30, 2021 | 299,000.00 |
| Jun 30, 2021 | 300,000.00 |
| Mar 31, 2021 | 281,000.00 |
| Dec 31, 2020 | 283,000.00 |
| Sep 30, 2020 | 2.03 Mn |
API Access
Legend Biotech Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();